Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Genetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid Leukemia
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2011-05-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 500
- Registration Number
- NCT01106144
- Locations
- π°π·
Samsung Medical Center IRB, Seoul, South Korea, Korea, Republic of
Study of Nilotinib in Metastatic Melanoma With KIT Aberrations
- First Posted Date
- 2010-04-07
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT01099514
- Locations
- π°π·
Samsung Cancer Center, Seoul, Korea, Republic of
A Trial of RAD001/Capecitabine in Refractory Gastric Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-04-07
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 59
- Registration Number
- NCT01099527
- Locations
- π°π·
Samsung Cancer Center, Seoul, Korea, Republic of
Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor
- First Posted Date
- 2010-04-07
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 37
- Registration Number
- NCT01099540
- Locations
- π°π·
Samsung Cancer Center, Seoul, Korea, Republic of
Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients
- First Posted Date
- 2010-04-06
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 207
- Registration Number
- NCT01099085
- Locations
- π°π·
Samsung Cancer Center, Seoul, Korea, Republic of
Predictors for Responsiveness to Corticosteroid in Patients With Early Acute Respiratory Distress Syndrome
Terminated
- Conditions
- First Posted Date
- 2010-03-25
- Last Posted Date
- 2012-06-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01093287
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Comparison of Harmonic Scalpel to Conventional Diathermy in Perforator Flap Elevation for Head and Neck Reconstruction
- First Posted Date
- 2010-03-25
- Last Posted Date
- 2011-10-04
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01092468
- Locations
- π°π·
Samsung medical center, Seoul, Korea, Republic of
Postoperative Cyclic Oral Contraceptive Use for the Prevention of Endometrioma Recurrence
- Conditions
- First Posted Date
- 2010-03-25
- Last Posted Date
- 2010-03-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 232
- Registration Number
- NCT01092494
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy
- First Posted Date
- 2010-03-25
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1580
- Registration Number
- NCT01092481
- Locations
- π°π·
National Cancer Center, Goyang, Gyeonggi, Korea, Republic of
π°π·Seoul St. Mary's hospital, Catholic Univerisity, Seoul, Korea, Republic of
π°π·SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of
Sorafenib for Imatinib/Sunitinib-failed GIST
- First Posted Date
- 2010-03-23
- Last Posted Date
- 2012-01-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 39
- Registration Number
- NCT01091207
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Β© Copyright 2024. All Rights Reserved by MedPath